Digestive Cancers Europe ASBL
4.8 FTEDigestive Cancers Europe reported total assets of €2.26m at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Aug 2026), with 4.8 full-time equivalents.
By total assets for 2025, Digestive Cancers Europe ranks in the top half of the 847 companies in its sector (NACE 9499) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Digestive Cancers Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +51 % Total assets +171 % Headcount (avg FTE) +118 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Digestive Cancers Europe's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 02 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 08 Sep 2022
Digestive Cancers Europe's financial analysis
- Solvency44.1%sector median: 44.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Digestive Cancers Europe
Digestive Cancers Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0717.836.325
- VAT number
- BE0717836325
- Peppol
- Registered · 0208:0717836325 · as of 10 Nov 2026
- Legal form
- ASBL
- Incorporated
- 09 Jan 2019
- Registered office
- 1040 Brussels
- Size
- Micro · 4.8 FTE
- Latest accounts
- 2025 · filed on 26 Aug 2026
- Activity
- Activities of illness prevention and health promotion associations (NACE 94993)
Digestive Cancers Europe (ASBL) has been based in Brussels since 2019, active in: activities of illness prevention and health promotion associations. For 2025, it reports a net profit of 17,847 € and equity of 999,232 €; its revenue is not published. With 4.8 full-time equivalents, it is a micro-enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Digestive Cancers Europe
Companies in the same business, of comparable size and area, outside its group.
- Ronald Mcdonald Kinderfonds - Fonds Ronald Mcdonald pour les Enfants Public relations and communication activities Jette · balance sheet €2.34m
- European Network on Debt and Development Public relations and communication activities Ixelles · balance sheet €2.23m
- European Diabetes Forum Public relations and communication activities Brussels · balance sheet 679,130 €
- Smart Energy Europe Public relations and communication activities Brussels · balance sheet €1.87m
- Ipopi Other support activities to arts and performing arts Ixelles · balance sheet €2.14m
- Cancer Drug Development Forum Activities of other membership organisations n.e.c. Woluwe-Saint-Lambert · balance sheet €1.67m
- European Investment Casters'Federation Business and other management consultancy activities Ixelles · balance sheet 766,956 €
- The Synergist Research and experimental development on social sciences and humanities Ixelles · balance sheet €5.01m
Frequently asked questions about Digestive Cancers Europe
What is the revenue of Digestive Cancers Europe?
Digestive Cancers Europe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Digestive Cancers Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0717836325 for Digestive Cancers Europe, if the company is VAT-registered. Its company number (CBE) is 0717.836.325.
Where is the registered office of Digestive Cancers Europe?
According to the CBE register, the registered office of Digestive Cancers Europe is in 1040 Brussels.
What is the equity of Digestive Cancers Europe?
At the close of the 2025 financial year, the equity of Digestive Cancers Europe amounts to 999,232 €, a solvency of 44.1% of total assets.
How many people work at Digestive Cancers Europe?
4.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Digestive Cancers Europe?
The register lists 6 active mandates at Digestive Cancers Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Digestive Cancers Europe within its sector?
By total assets for 2025, Digestive Cancers Europe ranks in the top half of the 847 companies in its sector (NACE 9499) in Belgium that filed accounts for that financial year.
The full file of Digestive Cancers Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →